Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $171.98 USD
Change Today -3.30 / -1.88%
Volume 2.2M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ALEXION PHARMACEUTICALS INC (ALXN)

Alexion Pharmaceuticals, Inc. to Report Q2, 2015 on Jul 30, 2015
CapIQ 07/30/2015 1:00 PM ET
Alexion Pharmaceuticals, Inc. to Report Q1, 2015 on Apr 23, 2015
CapIQ 07/30/2015 1:00 PM ET
Alexion Pharmaceuticals, Inc. to Report Q4, 2014 on Jan 29, 2015
CapIQ 07/30/2015 1:00 PM ET

2013 revenues at Alexion Pharmaceuticals, Inc. totaled $1.6B USD, while annual earnings equaled $3.08 per share.

Quarterly Earnings & Estimates - ALEXION PHARMACEUTICALS INC (ALXN)

Actuals vs. Estimates for ALEXION PHARMACEUTICALS INC ALXN

Alexion Pharmaceuticals, Inc.'s Quarterly Earnings

Alexion Pharmaceuticals, Inc. reported 2nd quarter 2014 earnings of $1.12 per share on 07/26/2014.

Annual Earnings & Estimates - ALEXION PHARMACEUTICALS INC (ALXN)

Actuals vs. Estimates for ALEXION PHARMACEUTICALS INC ALXN

Alexion Pharmaceuticals, Inc.'s Annual Earnings

Alexion Pharmaceuticals, Inc. reported annual 2013 earnings of $3.08 per share on 02/1/2014.

Quarterly Revenues - ALEXION PHARMACEUTICALS INC (ALXN)

Actuals vs. Estimates for ALEXION PHARMACEUTICALS INC ALXN

Alexion Pharmaceuticals, Inc.'s Quarterly Revenues

Alexion Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $512.5M USD. This bettered the $510.3M USD consensus of the 18 analysts covering the company. This was 38.5% above the prior year's 2nd quarter results.

Annual Revenues - ALEXION PHARMACEUTICALS INC (ALXN)

Actuals vs. Estimates for ALEXION PHARMACEUTICALS INC ALXN

Alexion Pharmaceuticals, Inc.'s Annual Revenues

Alexion Pharmaceuticals, Inc. had revenues for the full year 2013 of $1.6B USD. This was 36.8% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $171.98 USD -3.30

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Croda International PLC 2,799 GBp -57.00
Dr Reddy's Laboratories Ltd 4,053 INR 0.00
Sigma-Aldrich Corp $139.46 USD -0.10
Symrise AG €52.41 EUR -0.80
United Therapeutics Corp $149.21 USD -0.75
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 60.2x
Price/Sales 14.9x
Price/Book 4.7x
Price/Cash Flow 67.3x
TEV/Sales 14.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.